Balance Sheet Data
ADMA Biologics, Inc. (ADMA)
$3.735
+0.01 (+0.13%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 22.75 | 26.75 | 55.92 | 51.09 | 86.52 | 256.68 | 448.37 | 783.21 | 1,368.11 | 2,389.81 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 1.39 | 3.47 | 13.24 | 28.58 | 15.51 | 52.08 | 90.97 | 158.90 | 277.56 | 484.85 |
| Account Receivables (%) | ||||||||||
| Inventories | 18.62 | 53.06 | 81.54 | 124.72 | 163.28 | 400.27 | 699.19 | 1,221.34 | 2,133.43 | 3,726.67 |
| Inventories (%) | ||||||||||
| Accounts Payable | 5.90 | 9.17 | 11.07 | 12.43 | 13.23 | 62.53 | 109.23 | 190.81 | 333.30 | 582.21 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -2.10 | -3.81 | -12.73 | -13.51 | -13.91 | -43.70 | -76.34 | -133.35 | -232.94 | -406.91 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.